Search

everythinglearnresearchcommunity

for

Search:↓

TrichoSol™ effectively stabilizes various hair treatment ingredients for different durations.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Tunisian children with hereditary vitamin D-resistant rickets showed improvement with calcium treatment, and new genetic mutations were identified.

Oral cyclosporine combined with Pantogar® effectively treats twenty-nail dystrophy.

Tribulus terrestris may protect the liver from drug damage.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The model and estimator can predict drug exposure in kidney transplant patients well.

Tailored treatment is crucial for elderly men with BPH due to potential risks and benefits of medications.

The method accurately and quickly measures silodosin and dutasteride in mixtures.

Both concentrations of triamcinolone acetonide are effective for hair regrowth in patchy alopecia areata, but 5 mg/mL is recommended to reduce side effects.

Iron deficiency is common in kidney transplant patients, and while iron treatment helps, it can cause high red blood cell levels.

Applying a tretinoin cream can remove hair plugs and treat trichostasis spinulosa.

A new method allows for controlled, long-lasting delivery of retinoic acid through the skin with less inflammation.

Ritlecitinib may help young adults with severe alopecia areata when ketoconazole fails.

N-acetylcysteine may help treat trichotillomania.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tofacitinib may help treat hair loss in children with alopecia areata.

An 8-year-old with severe hair loss regrew all hair after six months of tofacitinib treatment.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.